Overview

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Status:
Completed
Trial end date:
2011-12-20
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of acute exacerbation of schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Gedeon Richter Ltd.
Treatments:
Aripiprazole
Cariprazine